Hydroxychloroquine Supplier Denies Its Amended Complaint Prejudices Manufacturer

( January 15, 2025, 1:53 PM EST) -- TRENTON, N.J. — A pharmaceutical supplier on Jan. 14 informed a New Jersey federal court that the striking of its second amended complaint (SAC), filed in connection with its purchase of large quantities of hydroxychloroquine and chloroquine phosphate from a manufacturer, is not warranted, maintaining that the SAC neither adds nor removes counts from the proposed version and simply adds facts in support of the counts it was permitted to amend....

Attached Documents

Related Sections